398 related articles for article (PubMed ID: 20501830)
1. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
2. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
Uekita T; Sakai R
Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
[TBL] [Abstract][Full Text] [Related]
3. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
[TBL] [Abstract][Full Text] [Related]
4. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
[TBL] [Abstract][Full Text] [Related]
5. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
[TBL] [Abstract][Full Text] [Related]
6. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
[TBL] [Abstract][Full Text] [Related]
8. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.
Cao M; Gao J; Zhou H; Huang J; You A; Guo Z; Fang F; Zhang W; Song T; Zhang T
Tumour Biol; 2016 Feb; 37(2):1651-62. PubMed ID: 26307391
[TBL] [Abstract][Full Text] [Related]
9. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
Ikeda J; Oda T; Inoue M; Uekita T; Sakai R; Okumura M; Aozasa K; Morii E
Cancer Sci; 2009 Mar; 100(3):429-33. PubMed ID: 19077003
[TBL] [Abstract][Full Text] [Related]
10. Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.
Seidel J; Kunc K; Possinger K; Jehn C; Lüftner D
Biochem Biophys Res Commun; 2011 Oct; 414(1):226-32. PubMed ID: 21945930
[TBL] [Abstract][Full Text] [Related]
11. Ezrin interacts with cortactin to form podosomal rosettes in pancreatic cancer cells.
Kocher HM; Sandle J; Mirza TA; Li NF; Hart IR
Gut; 2009 Feb; 58(2):271-84. PubMed ID: 18852256
[TBL] [Abstract][Full Text] [Related]
12. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells.
Miura S; Hamada S; Masamune A; Satoh K; Shimosegawa T
Exp Cell Res; 2014 Feb; 321(2):209-18. PubMed ID: 24384474
[TBL] [Abstract][Full Text] [Related]
13. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.
Gandji LY; Proust R; Larue L; Gesbert F
PLoS One; 2015; 10(4):e0123472. PubMed ID: 25876044
[TBL] [Abstract][Full Text] [Related]
15. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
[TBL] [Abstract][Full Text] [Related]
16. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
17. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
18. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
19. Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix.
Sarkar S; Yong VW
Carcinogenesis; 2010 Feb; 31(2):311-7. PubMed ID: 19965895
[TBL] [Abstract][Full Text] [Related]
20. High-constitutive HuR phosphorylation at Ser 318 by PKC{delta} propagates tumor relevant functions in colon carcinoma cells.
Doller A; Winkler C; Azrilian I; Schulz S; Hartmann S; Pfeilschifter J; Eberhardt W
Carcinogenesis; 2011 May; 32(5):676-85. PubMed ID: 21310943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
